These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. International trends in spice use: Prevalence, motivation for use, relationship to other substances, and perception of use and safety for synthetic cannabinoids. Loeffler G; Delaney E; Hann M Brain Res Bull; 2016 Sep; 126(Pt 1):8-28. PubMed ID: 27108542 [TBL] [Abstract][Full Text] [Related]
15. Synthetic Cannabis and Myocardial Infarction: A Complication Less Known! Hirapara K; Aggarwal R Psychosomatics; 2015; 56(6):712-3. PubMed ID: 26674489 [No Abstract] [Full Text] [Related]
16. Illicit Drugs and their Impact on Cardiovascular Pathology. Bădilă E; Hostiuc M; Weiss E; Bartoş D Rom J Intern Med; 2015; 53(3):218-25. PubMed ID: 26710497 [TBL] [Abstract][Full Text] [Related]
17. A case of ischemic stroke after bonzai: syntetic cannabinoid from Turkey. Degirmenci Y; Kececi H; Olmez N Neurol Sci; 2016 Feb; 37(2):299-300. PubMed ID: 26466589 [No Abstract] [Full Text] [Related]
18. Could spice drugs induce psychosis with abnormal movements similar to catatonia? Haro G; Ripoll C; Ibáñez M; Orengo T; Liaño VM; Meneu E; Hernández F; Traver F Psychiatry; 2014; 77(2):206-8. PubMed ID: 24865202 [No Abstract] [Full Text] [Related]
19. Myocardial infarction associated with use of the synthetic cannabinoid K2. Mir A; Obafemi A; Young A; Kane C Pediatrics; 2011 Dec; 128(6):e1622-7. PubMed ID: 22065271 [TBL] [Abstract][Full Text] [Related]